Skip to main content

Table 2 Echocardiographic characteristics of the whole CHF population classified as Euglycemic, IR, and DM

From: Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry

Characteristics Study cohort Euglycemic (n = 172) IR (n = 188) T2D (n = 120) ANOVA F-value p-value
IVSd (mm) 10.6 ± 2 10 ± 2 10 ± 2 11 ± 2*§ 6.1  < 0.05
LVEDd (mm) 62.7 ± 8.4 63.2 ± 8.4 62.9 ± 8.8 62.0 ± 8.0 0.4 0.6
PWd (mm) 9.6 ± 1.5 9.5 ± 1.5 9.6 ± 1.5 9.8 ± 1.6 1.3 0.3
LVEDVi (ml/m2) 97.8 ± 38.2 99.1 ± 33.6 100 ± 43.2 93.2 ± 36.4 1.1 0.3
RWT (IVSd + PWd)/LVEDd 0.33 ± 0.1 0.32 ± 0.1 0.32 ± 0.1 0.34 ± 0.1§* 4.7  < 0.05
LVMi 145 ± 44 139 ± 29 146 ± 37 150 ± 85 1.4 0.3
LAVi (ml/m2) 42.7 ± 21.3 38.3 ± 17.2 43.0 ± 19.0 48.0 ± 26.4* 5.8  < 0.01
E velocity (cm/sec) 73.2 ± 26.0 73.3 ± 26.2 69.9 ± 22.0 77.5 ± 30.0§ 2.1 0.12
E/e′ 14 ± 8 12 ± 6 14 ± 8* 16 ± 9§* 6.1  < 0.01
PASP (mmHg) 37 ± 14.5 38 ± 15 35 ± 15 39 ± 15 2.4 0.1
TAPSE 18.7 ± 4.6 19.1 ± 4.7 18.7 ± 4.6 18.2 ± 4.5 1.4 0.2
TAPSE/PASP 0.6 ± 4.6 0.6 ± 0.3 0.6 ± 0.3 0.52 ± 0.2§* 3.2  < 0.05
Moderate/severe tricuspid regurgitation (n; %) 112; 23 36; 21 41; 22 35; 29 4.2  < 0.1
RVDd (mm) 36.3 ± 9.5 37.3 ± 7.6 36.5 ± 11.2 34.9 ± 9.0 0.8 0.4
RVFAC (%) 55 ± 12 56.5 ± 10.7 55.9 ± 11.6 53.5 ± 13,5 1.6 0.5
RADVi (ml/m2) 30 ± 16 26 ± 13 30 ± 14 34 ± 19* 4.0  < 0.05
  1. IVSd, Inter Ventricular Septum Diastole; LVEDd, Left Ventricular End Diastolic Diameter; PWd, Posterior Wall Diastole; LVEDVi, LVEDV/BSA (Left Ventricular End Diastolic Volume/BSA); RWT, Relative Wall Thickness; LVMi, LVM/BSA (Left Ventricular Mass/BSA); LAVi, LAV/BSA (Left Atrial Volume/BSA); E Velocity; PAPS, Pulmonary Artery Systolic Pressure; TAPSE, Tricuspid Annular Plane Systolic Excursion; RVDd, Right Ventricular Diastolic Diameter; RVFAC, Right ventricular fractional area change; RADVi, RADV/BSA (Right Atrial Diastolic Volume/BSA)
  2. *p < 0.05 respect Euglycemic
  3. §p < 0.05 respect IR